Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Supply
Biotech
EpimAb reels in $120M to propel 3 clinical-stage bispecifics
The funding will push three programs through teh clinic, including a dual checkpoint inhibitor and a T-cell engager that targets CD3 and BCMA.
Amirah Al Idrus
Mar 22, 2021 7:00pm
Sanofi, hit by COVID-19 vaccine setback, kick-starts mRNA trial
Mar 12, 2021 10:44am
PhaseBio taps a manufacturing partner for Brilinta-reversing med
Mar 11, 2021 9:50am
Merck must do a new trial for faltering $425M COVID-19 drug
Mar 3, 2021 7:55am
UCB taps Microsoft to accelerate drug discovery, clinical trials
Feb 24, 2021 8:35am
Janssen sends off phase 3 data for a swift WHO pandemic listing
Feb 19, 2021 9:00am
